Kiora Pharmaceuticals Inc（KPRX）價格預測KPRXKiora Pharmaceuticals Inc

Alphio's KPRX stock price prediction model matches the current Kiora Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.67 (+1.80%). The 1-week path is $2.68 (+2.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiora Pharmaceuticals Inc is currently not a strong buy due to its recent financial losses and lack of profitability. The stock price is at $2.62, with a forward P/E ratio of 2.41, indicating potential undervaluation, but the company has reported a loss of $0.58 per share in Q1 2026. The RSI is at 49.46, suggesting the stock is neither overbought nor oversold, which means it may not be the best time to buy. The main risk is the negative earnings trend, with a projected EPS of -0.34 for the last quarter, indicating ongoing financial challenges.

Kiora Pharmaceuticals Inc (KPRX) last closed at $2.62, losing -1.50%. These facts feed the 1-day and 1-week KPRX price prediction above.